Cavalcante SC - Search Results

1

AIDS-related tuberculosis in Rio de Janeiro, Brazil.

Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, Chaisson RE, Golub JE. Pacheco AG, et al. Among authors: cavalcante sc. PLoS One. 2008 Sep 10;3(9):e3132. doi: 10.1371/journal.pone.0003132. PLoS One. 2008. PMID: 18781195 Free PMC article.

2

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Moore RD, et al. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1013-9. doi: 10.1164/ajrccm.154.4.8887600. Am J Respir Crit Care Med. 1996. PMID: 8887600

3

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD. Chaisson RE, et al. Am J Med. 2001 Jun 1;110(8):610-5. doi: 10.1016/s0002-9343(01)00695-7. Am J Med. 2001. PMID: 11382368 Clinical Trial.

4

Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City.

Soares EC, Pacheco AG, Mello FC, Durovni B, Chaisson RE, Cavalcante SC. Soares EC, et al. Among authors: cavalcante sc. Int J Tuberc Lung Dis. 2006 Jun;10(6):690-5. Int J Tuberc Lung Dis. 2006. PMID: 16776458

5

The cost-effectiveness of DOTS in urban Brazil.

Mohan CI, Bishai D, Cavalcante S, Chaisson RE. Mohan CI, et al. Int J Tuberc Lung Dis. 2007 Jan;11(1):27-32. Int J Tuberc Lung Dis. 2007. PMID: 17217126

6

Tuberculosis as a disease defining acquired immunodeficiency syndrome: ten years of surveillance in Rio de Janeiro, Brazil.

Soares EC, Saraceni V, Lauria Lde M, Pacheco AG, Durovni B, Cavalcante SC. Soares EC, et al. Among authors: cavalcante sc. J Bras Pneumol. 2006 Sep-Oct;32(5):444-8. J Bras Pneumol. 2006. PMID: 17268749 Free article. English, Portuguese.

7

Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.

Cavalcante SC, Soares EC, Pacheco AG, Chaisson RE, Durovni B; DOTS Expansion Team. Cavalcante SC, et al. Int J Tuberc Lung Dis. 2007 May;11(5):544-9. Int J Tuberc Lung Dis. 2007. PMID: 17439679

8

Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention.

Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, King B, Chaisson RE. Moulton LH, et al. Among authors: cavalcante sc. Clin Trials. 2007;4(2):190-9. doi: 10.1177/1740774507076937. Clin Trials. 2007. PMID: 17456522 Clinical Trial.

9

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. Golub JE, et al. Among authors: cavalcante sc. AIDS. 2007 Jul 11;21(11):1441-8. doi: 10.1097/QAD.0b013e328216f441. AIDS. 2007. PMID: 17589190 Free PMC article.

10

Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.

Saraceni V, King BS, Cavalcante SC, Golub JE, Lauria LM, Moulton LH, Chaisson RE, Durovni B. Saraceni V, et al. Among authors: cavalcante sc. Int J Tuberc Lung Dis. 2008 Jul;12(7):769-72. Int J Tuberc Lung Dis. 2008. PMID: 18544202 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters